Cargando…
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
INTRODUCTION: The term progressive fibrosing interstitial lung disease (ILD) describes patients with fibrotic ILDs who, irrespective of the aetiology of the disease, show a progressive course of their disease despite current available (and non-licensed) treatment. Besides in idiopathic pulmonary fib...
Autores principales: | Wuyts, Wim A., Papiris, Spyridon, Manali, Effrosyni, Kilpeläinen, Maritta, Davidsen, Jesper Rømhild, Miedema, Jelle, Robalo-Cordeiro, Carlos, Morais, Antonio, Artés, Maite, Asijee, Guus, Cendoya, David, Soulard, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467418/ https://www.ncbi.nlm.nih.gov/pubmed/32445186 http://dx.doi.org/10.1007/s12325-020-01384-0 |
Ejemplares similares
-
Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study
por: Davidsen, Jesper Rømhild, et al.
Publicado: (2020) -
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
por: Hilberg, Ole, et al.
Publicado: (2022) -
Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting
por: Kilpeläinen, Maritta, et al.
Publicado: (2023) -
Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
por: Manali, Effrosyni D., et al.
Publicado: (2023) -
Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)